Complete report details @ https://www.wiseguyreports.com/reports/649784-osteoarthritis-pipeline-review-h2-2016
Summary
‘Osteoarthritis -
Pipeline Review, H2 2016’, provides an overview of the Osteoarthritis pipeline
landscape.
The report provides comprehensive information on the
therapeutics under development for Osteoarthritis, complete with analysis by
stage of development, drug target, mechanism of action (MoA), route of
administration (RoA) and molecule type. The report also covers the descriptive
pharmacological action of the therapeutics, its complete research and
development history and latest news and press releases. Additionally, the
report provides an overview of key players involved in therapeutic development
for Osteoarthritis and features dormant and discontinued projects.
Report features investigational drugs from across globe covering
over 20 therapy areas and nearly 3,000 indications. The report is built using
data and information sourced from proprietary databases, company/university
websites, clinical trial registries, conferences, SEC filings, investor
presentations and featured press releases from company/university sites and
industry-specific third party sources. Drug profiles featured in the report
undergoes periodic review following a stringent set of processes to ensure that
all the profiles are updated with the latest set of information. Additionally,
various dynamic tracking processes ensure that the most recent developments are
captured on a real time basis.
The report helps in identifying and tracking emerging players in
the market and their portfolios, enhances decision making capabilities and helps
to create effective counter strategies to gain competitive advantage.
Request a sample report @ https://www.wiseguyreports.com/sample-request/649784-osteoarthritis-pipeline-review-h2-2016
Scope
- The report provides a snapshot of the global therapeutic
landscape of Osteoarthritis
- The report reviews pipeline therapeutics for Osteoarthritis by companies and universities/research institutes based on information derived from company and industry-specific sources
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report reviews key players involved Osteoarthritis therapeutics and enlists all their major and minor projects
- The report assesses Osteoarthritis therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
- The report summarizes all the dormant and discontinued pipeline projects
- The report reviews latest news related to pipeline therapeutics for Osteoarthritis
- The report reviews pipeline therapeutics for Osteoarthritis by companies and universities/research institutes based on information derived from company and industry-specific sources
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report reviews key players involved Osteoarthritis therapeutics and enlists all their major and minor projects
- The report assesses Osteoarthritis therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
- The report summarizes all the dormant and discontinued pipeline projects
- The report reviews latest news related to pipeline therapeutics for Osteoarthritis
Make an
enquiry before buying this Report @ https://www.wiseguyreports.com/enquiry/649784-osteoarthritis-pipeline-review-h2-2016
Reasons
to buy
- Gain strategically significant competitor information,
analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of therapeutics under development for Osteoarthritis
- Identify potential new clients or partners in the target demographic
- Develop strategic initiatives by understanding the focus areas of leading companies
- Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Osteoarthritis pipeline depth and focus of Indication therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of therapeutics under development for Osteoarthritis
- Identify potential new clients or partners in the target demographic
- Develop strategic initiatives by understanding the focus areas of leading companies
- Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Osteoarthritis pipeline depth and focus of Indication therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline
Check Discount on this report @ https://www.wiseguyreports.com/check-discount/649784-osteoarthritis-pipeline-review-h2-2016
Table of Contents
Table of Contents 2
Introduction 6
Osteoarthritis Overview 7
Therapeutics Development 8
Osteoarthritis - Therapeutics under Development by Companies 10
Osteoarthritis - Therapeutics under Investigation by Universities/Institutes 15
Osteoarthritis - Pipeline Products Glance 16
Osteoarthritis - Products under Development by Companies 19
Osteoarthritis - Products under Investigation by Universities/Institutes 25
Osteoarthritis - Companies Involved in Therapeutics Development 26
Osteoarthritis - Therapeutics Assessment 82
Drug Profiles 96
Osteoarthritis - Dormant Projects 244
Osteoarthritis - Discontinued Products 254
Osteoarthritis - Product Development Milestones 256
Appendix 268
Table of Contents 2
Introduction 6
Osteoarthritis Overview 7
Therapeutics Development 8
Osteoarthritis - Therapeutics under Development by Companies 10
Osteoarthritis - Therapeutics under Investigation by Universities/Institutes 15
Osteoarthritis - Pipeline Products Glance 16
Osteoarthritis - Products under Development by Companies 19
Osteoarthritis - Products under Investigation by Universities/Institutes 25
Osteoarthritis - Companies Involved in Therapeutics Development 26
Osteoarthritis - Therapeutics Assessment 82
Drug Profiles 96
Osteoarthritis - Dormant Projects 244
Osteoarthritis - Discontinued Products 254
Osteoarthritis - Product Development Milestones 256
Appendix 268
Contact US:
NORAH TRENT
Partner Relations
& Marketing Manager
sales@wiseguyreports.com
Ph:
+1-646-845-9349 (US)
Ph:
+44 208 133 9349 (UK)
No comments:
Post a Comment